Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Ruzagira, Eugene ^a   Wandiembe, Symon ^a   Abaasa, Andrew ^a   Levin, Jonathan ^a   Bwanika, Agnes ^a   Bahemuka, Ubaldo ^a   Price, Matthew A ^b   Kamali, Anatoli ^a  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS VACCINE;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG RESEARCH; FEMALE; GENITAL ULCER; HEALTH SURVEY; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT COUNSELING; PREVALENCE; RISK FACTOR; RURAL POPULATION; SAMPLE SIZE; SEROCONVERSION; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL BEHAVIOR; UGANDA; VIRUS TRANSMISSION; ADOLESCENT; DISEASE TRANSMISSION; HEALTH; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL HEALTH; RURAL POPULATION; UGANDA; VIRAL VACCINES; YOUNG ADULT;

EID: 79958036390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020684     Document Type: Article

References (18)

1. Esparza J, (2001) An HIV vaccine: how and when? Bulletin of the World Health Organization 79: 1133-1137.
2. UNAIDS/WHO (2009) AIDS epidemic update Geneva UNAIDS.
3. Vardas E, Buttò S, Glashoff R, Malnati SM, Poli G, et al. (2005) Preparing for phase II/III HIV vaccine trials in Africa. Microbes and Infection 7: 1436-1444.
4. Kamali A, Kinsman J, Nalweyiso N, Mitchell K, Kanyesigye E, et al. (2002) A community randomized controlled trial to investigate impact of improved STD management and behavioural interventions on HIV incidence in rural Masaka, Uganda: trial design, methods and baseline findings. Tropical Medicine and International Health 7: 1053-1063.
5. Victora GC, Huttly RS, Fuchs CS, Olinto AMT, (1997) The Role of Conceptual Frameworks in Epidemiological Analysis: A Hierarchical Approach. International Journal of Epidemiology 26: 224-227.
6. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1. New England Journal of Medicine 342: 921-929.
7. Carpenter LM, Kamali A, Ruberantwari A, Malamba S, Whitworth J, (1999) Rates of HIV transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners. AIDS 13: 1083-1089.
8. Hugonnet S, Mosha F, Todd J, Mugeye K, Klokke A, et al. (2002) Incidence of HIV infection in stable sexual partnerships: A retrospective cohort study of 1802 couples in Mwanza Region, Tanzania. J Acquir Immune Defic Syndr 30: 73-80.
9. Auvert B, Buvé A, Ferry B, Caraël M, Morison L, et al. (2001) Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 15: S15-S30.
10. Sateren WB, Foglia G, Renzullo PO, Eslon L, Wassuna M, et al. (2006) Epidemiology of HIV-1 Infection in Agricultural Plantation Residents in Kericho, Kenya: Preparation for Vaccine Feasibility Studies. J Acquir Immune Defic Syndr 43: 102-106.
11. Amornkul NP, Vandenhoudt H, Nasokho P, Odhiambo F, Mwaengo D, et al. (2009) HIV Prevalence and Associated Risk Factors among Individuals Aged 13-34 Years in Rural Western Kenya. Plos One 4: e6470.
12. Biraro S, Shafer LA, Kleinschmidt I, Wolff B, Karabalinde A, et al. (2009) Is Sexual risk taking behaviour changing in rural south-west Uganda? Behaviour trends in a rural population cohort 1993-2006. Sexually Transmitted Infections 85: i3-i11.
13. Dickerson MC, Johnston JBA, Delea TE, White A, Andrews E, (1996) The Causal Role for Genital Ulcer Disease as a Risk Factor for Transmission of Human Immunodeficiency Virus: An Application of the Bradford Hill Criteria. Sexually Transmitted Diseases 23: 429-440.
14. Esparza J, Burke D, (2001) Epidemiological considerations in planning HIV preventive vaccine trials. AIDS 15: 49-57.
15. Ruzagira E, Wandiembe S, Bufumbo L, Levin J, Price AM, et al. (2009) Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Tropical Medicine and International Health 14: 1-8.
16. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, et al. (2003) Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. The Lancet 361: 645-652.
17. Stover J, Garnett GP, Seitz S, Forsythe S, (2002) The Epidemiological Impact of an HIV/AIDS Vaccine in Developing Countries Policy Research Working Paper 2811:World Bank.
18. Nunn AJ, Wagner H, Kamali A, Kengeya-Kayondo J, Mulder D, (1995) Migration and HIV-1 seroprevalence in a rural Ugandan population. AIDS 9: 503-506.